TRANSJUGULAR INTRAHEPATIC PORTASYSTEMIC STENT SHUNT [PDF]
Transjugular intrahepatic portosystemic stent shunt (TIPSS) is a new non-surgical method of creating a portasystemic communication [1]. It is yet another innovative technique for the prevention of bleeding from oesophageal varices in patients of portal hypertension.
K M Harikrishnan
exaly +6 more sources
Diversas alternativas terapêuticas têm sido usadas, atualmente, na tentativa de reduzir a mortalidade de pacientes com hipertensão portal que desenvolvem varizes esofagianas.
Gerson CARREIRO +4 more
doaj +2 more sources
Development of pseudointima and stenosis after transjugular intrahepatic portasystemic shunts: Characterization of cell phenotype and function [PDF]
The clinical utility of transjugular intrahepatic portasystemic shunts (TIPS) is frequently complicated by the ingrowth of tissue into the stent lumen, causing stent stenosis. These studies were undertaken to define the cellular and matrix components of the pseudointima, define the phenotype and function of the mesenchymal ...
, Martin F Graham
exaly +3 more sources
Endothelial cells lining transjugular intrahepatic portasystemic shunts originate in hepatic sinusoids: Implications for pseudointimal hyperplasia [PDF]
The phenotype of the endothelial cells (ECs) in the pseudointima of transjugular intrahepatic portasystemic shunts (TIPS) and the mechanisms of pseudointima formation after TIPS were unknown. We hypothesized that TIPS were lined by hepatic sinusoidal ECs, which stimulated the migration of smooth muscle cells (SMCs) into the ...
exaly +3 more sources
Abstract Background Transjugular intrahepatic portasystemic stent shunt (TIPSS), instead of surgical shunt, has become the standard treatment for patients with complicated portal hypertension. This study compared outcomes in patients who underwent TIPSS or surgical shunting for complicated portal ...
Masaru Miyazaki, Marc Antoine Allard
exaly +3 more sources
Transjugular intrahepatic portasystemic stent shunting for control of acute and recurrent upper gastrointestinal haemorrhage related to portal hypertension. [PDF]
The insertion of a transjugular intrahepatic portasystemic stent shunt (TIPSS) was evaluated in 22 patients with recurrent upper gastrointestinal haemorrhage related to portal hypertension (bleeding from oesophageal varices 10, gastric varices six, portal hypertensive gastropathy six).
, K J Simpson, D N Redhead
exaly +3 more sources
The authors compare transjugular intrahepatic portasystemic stent shunts (TIPS) to small-diameter prosthetic H-graft portacaval shunts (HGPCS).Transjugular intrahepatic portasystemic stent shunts have been embraced as a first-line therapy in the treatment of bleeding varices due to portal hypertension, although they have not been compared to ...
A S Rosemurgy +2 more
exaly +4 more sources
Is transjugular intrahepatic portasystemic shunt a panacea for the complications of portal hypertension? [PDF]
T D Boyer
exaly +2 more sources
Treating systemic inflammation by transjugular intrahepatic portosystemic shunt: Editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis” [PDF]
Georg Semmler +2 more
doaj +2 more sources
Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)
A stepwise treatment strategy of cirrhotic portal vein thrombosis recommended by the Chinese consensus. Portal vein thrombosis (PVT) is a common and severe complication of liver cirrhosis. So far, there have been few consensuses or practice guidelines on the management of PVT in liver cirrhosis.
Hepatobiliary Disease Study Group +2 more
wiley +1 more source

